IDH1 and central nervous system cancer: The occurrence of a CpG island hyper-methylator phenotype (CIMP) is a second change linked to IDH1 mutations, which displays distinct CpG island methylation at a more significant number of locations than non-IDH1 mutants and primary GB, according to a genome-wide methylation profile investigation in gliomas.